Is BlackRock a Buy, Sell or Hold
With a large suite of ETF offerings as well as…
Sell
44
MPW Quote, Financials, Valuation and Earnings
Last price:
$5.46
Seasonality move
:
1.68%
Day range:
$5.39 - $5.54
52-week range:
$3.51 - $6.55
Dividend yield:
9.91%
P/E ratio:
--
P/S ratio:
3.29x
P/B ratio:
0.68x
Volume:
8.8M
Avg. volume:
11.1M
1-year change:
14.26%
Market cap:
$3.3B
Revenue:
$995.5M
EPS (TTM):
-$4.03
Analysts' Opinion
-
Consensus RatingMedical Properties Trust has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $5.50, Medical Properties Trust has an estimated upside of 0.92% from its current price of $5.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing 100% downside risk from its current price of $5.45.
Fair Value
-
According to the consensus of 6 analysts, Medical Properties Trust has 0.92% upside to fair value with a price target of $5.50 per share.
MPW vs. S&P 500
-
Over the past 5 trading days, Medical Properties Trust has overperformed the S&P 500 by 7.03% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Medical Properties Trust does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medical Properties Trust revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Medical Properties Trust reported revenues of $231.8M.
Earnings Growth
-
Medical Properties Trust earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Medical Properties Trust reported earnings per share of -$0.69.
Enterprise value:
11.8B
EV / Invested capital:
--
Price / LTM sales:
3.29x
EV / EBIT:
30.48x
EV / Revenue:
11.84x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
48.03x
Price / Operating cash flow:
13.33x
Enterprise value / EBITDA:
14.03x
Gross Profit (TTM):
$968.3M
Return On Assets:
-14.82%
Net Income Margin (TTM):
-242.11%
Return On Equity:
-39.12%
Return On Invested Capital:
-15.37%
Operating Margin:
55.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $871.8M | $995.5M | -$122.4M | $231.8M | |
| Gross Profit | $1.5B | $830.2M | $968.3M | -$125.7M | $222.1M | |
| Operating Income | $1B | $81.3M | $386.8M | -$233.1M | $128.6M | |
| EBITDA | $1.3B | $697.4M | $840.6M | -$120.5M | $2.1B | |
| Diluted EPS | $1.50 | -$0.94 | -$4.03 | -$1.11 | -$0.69 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2B | $1.4B | $1.7B | $1.4B | $1.3B | |
| Total Assets | $16.8B | $20.5B | $19.7B | $18.3B | $14.3B | |
| Current Liabilities | $640.3M | $2.2B | $1.6B | $2B | $845.4M | |
| Total Liabilities | $9.5B | $12.1B | $11.1B | $10.7B | $9.5B | |
| Total Equity | $7.3B | $8.4B | $8.6B | $7.6B | $4.8B | |
| Total Debt | $8.9B | $11.3B | $10.3B | $10.1B | $8.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $739M | $505.8M | $245.5M | $135.4M | $76.7M | |
| Cash From Investing | $396.1M | $517.6M | $1.3B | $170.2M | $91.7M | |
| Cash From Financing | -$1.3B | -$1B | -$1.5B | -$402.7M | -$99.8M | |
| Free Cash Flow | $739M | $505.8M | $245.5M | $135.4M | $76.7M | |
MPW
Sector
Market Cap
$3.3B
$968.6M
Price % of 52-Week High
83.21%
79.49%
Dividend Yield
9.91%
3.35%
Shareholder Yield
--
3.41%
1-Year Price Total Return
14.26%
-0.89%
Beta (5-Year)
1.272
0.770
Dividend yield:
9.91%
Annualized payout:
$0.46
Payout ratio:
-13.32%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$5.31
200-day SMA
Buy
Level
$4.85
Bollinger Bands (100)
Buy
Level
4.04 - 5.58
Chaikin Money Flow
Sell
Level
-12.8M
20-day SMA
Sell
Level
$5.66
Relative Strength Index (RSI14)
Sell
Level
47.57
ADX Line
Sell
Level
32.44
Williams %R
Neutral
Level
-45.7797
50-day SMA
Sell
Level
$5.47
MACD (12, 26)
Sell
Level
-0.07
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Sell
Level
-618M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.0096)
Sell
CA Score
(Annual)
Level (-0.8751)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.8801)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.
Stock Forecast FAQ
In the current month, MPW has received 0 Buy ratings 5 Hold ratings, and 1 Sell ratings. The MPW average analyst price target in the past 3 months is $5.50.
-
Where Will Medical Properties Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medical Properties Trust share price will rise to $5.50 per share over the next 12 months.
-
What Do Analysts Say About Medical Properties Trust?
Analysts are divided on their view about Medical Properties Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Medical Properties Trust is a Buy and believe this share price will drop from its current level to $9.00.
-
What Is Medical Properties Trust's Price Target?
The price target for Medical Properties Trust over the next 1-year time period is forecast to be $5.50 according to 6 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is MPW A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medical Properties Trust is a Hold. 5 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of MPW?
You can purchase shares of Medical Properties Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medical Properties Trust shares.
-
What Is The Medical Properties Trust Share Price Today?
Medical Properties Trust was last trading at $5.46 per share. This represents the most recent stock quote for Medical Properties Trust. Yesterday, Medical Properties Trust closed at $5.45 per share.
-
How To Buy Medical Properties Trust Stock Online?
In order to purchase Medical Properties Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy, Sell or Hold?
Uber (NYSE:UBER) has been through quite a ride over the…
Is Micron a Good Stock to Buy Now?
Like most of its peers in the semiconductor industry, Micron…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 32x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Sell
23
UNH alert for Apr 18
UnitedHealth Group [UNH] is down 22.4% over the past day.
Sell
32
MAN alert for Apr 18
ManpowerGroup [MAN] is down 19.07% over the past day.
Sell
24
GPN alert for Apr 18
Global Payments [GPN] is down 17.44% over the past day.
